DOCSLIB.ORG

Abstract Book of the 3Rd Annual Scientific Meeting of the One Health EJP

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Abstract Book of the 3Rd Annual Scientific Meeting of the One Health EJP One Health EJP Annual Scientific Meeting 2021 9-11 June in Copenhagen, Denmark and online Abstract Book of the 3rd Annual Scientific Meeting of the One Health EJP Hosted by Statens Serum Institut and National Food Institute at the Technical University of Denmark This event is organized by the European Joint Programme One Health EJP, which has received funding from the European Union’s Horizon 2020 research and innovation programme under Grant Agreement No 773830. One Health EJP Annual Scientific Meeting 2021 2 Contents Keynote speakers 3 List of oral presentations 5 Oral presentation abstracts 6 List of poster presentations 36 Poster presentation abstracts 41 Local Organising One Health EJP Scientific Committee ASM Team Committee Pikka Jokelainen Pikka Jokelainen Pikka Jokelainen SSI, Conference Chair Denmark Julio Álvarez Sánchez Lars Villiam Pallesen Hein Imberechts Virginia Filipello SSI Belgium Alberto Mantovani Eva Møller Nielsen Arnaud Callegari SSI France Roberto La Ragione Guido Benedetti Roberto La Ragione Karin Artursson SSI United Kingdom Hein Imberechts Diana Connor Karin Artursson SSI Sweden Dorte Lau Baggesen Jade Passey DTU FOOD United Kingdom Rene S. Hendriksen Piyali Basu DTU FOOD United Kingdom Johanne Ellis-Iversen Elaine Campling DTU FOOD United Kingdom KEYNOTE SPEAKERS 3 Confronting AMR in times of a pandemic: A global survey on the impacts of COVID-19 on AMR Surveillance, Prevention and Control Sara Tomczyk Dr. Sara Tomczyk is with the Robert Koch Institute’s Unit on Healthcare-associated Infections, Surveillance of Antibiotic Resistance and Consumption in Berlin, Germany. She leads the unit’s international team including their work as the coordinator of the WHO AMR Surveillance and Quality Assessment Collaborating Centres Network. Prior to this, she has worked on a range of other IPC/AMR-related research and outbreak response teams internationally including several years with the WHO IPC Global Hub. She completed the CDC Epidemic Intelligence Service and Preventive Medicine Residency and has a Masters in Epidemiology from the London School of Hygiene and Tropical Medicine. 25 Years DANMAP – past, present and future aspects of an integrated approach to AMR and AMU surveillance Berit Müller-Pebody Dr. Berit Müller-Pebody is an Infectious Disease Epidemiologist and Chief Consultant at the AMR Reference Laboratory at the Statens Serum Institut, Copenhagen, Denmark. Berit has a special interest in the surveillance and research of antimicrobial resistance and prescribing, One Health initiatives and data visualisation & linkage methods. She is member of the Danish Integrated Antimicrobial Resistance Monitoring and Research Programme’s (DANMAP) Steering Committee. Birgitte Borck Høg Dr. Birgitte Borck Høg works as Senior Academic Officer at the Division for Global Surveillance, National Food Institute, Technical University of Denmark. Birgitte has a special interest in One Health initiatives and integrated approaches to surveillance. In her work, she has focus on data quality and assurance, multi-sectorial collaboration, as well as communication of results to different audiences. She has worked with different aspects of monitoring and surveillance of zoonoses, including the national control programmes for Salmonella and Campylobacter. Since 2011, she has worked with the Danish integrated Antimicrobial Resistance Monitoring and Research Programme, DANMAP, where she is part of the editorial team and co-author of the DANMAP report, and member of the DANMAP Steering Committee. Important One Health aspects of azole-resistant Aspergillus fumigatus Maiken Cavling Arendrup Prof. Arendrup is Professor at the University Hospital Rigshospitalet in Copenhagen and the Head of the Mycology Unit at Statens Serum Institut, Copenhagen, where she is responsible for the fungal laboratory, which receives 13,000 routine and reference samples per year for culture, susceptibility testing, antigen- and antibody- detection, and PCR, as well as for the national surveillance programmes of candidaemia and of azole resistance in Aspergillus. Prof. Arendrup was the founder of the Nordic Society of Medical Mycology (NSMM). She is chair of the EUCAST Antifungal Susceptibility Testing Subcommittee Steering Committee, and head of the EUCAST Development Laboratory for fungi. Prof. Arendrup has authored approx. 250 publications in international journals and as book chapters. Her main research interests include the epidemiology, susceptibility, breakpoint development, diagnostics and treatment of fungal infections. Rasmus Krøger Hare Rasmus Hare completed his Master’s in Biotechnology at the Technical University of Denmark before joining the mycology unit at Statens Serum Institut, Copenhagen Denmark. For >10 years he has been responsible for development and implementation of molecular assays for the diagnosis of superficial and complicated invasive fungal infections. During this period, he completed a PhD on antifungal drug resistance, involving a thorough understanding of resistance mechanisms and genotyping. This involved research visits at the esteemed centres of PHRI (now Rutgers, New Jersey, USA) and Canisius Wilhelmina Hospital (Nijmegen, Holland). He is a Board member and web-moderator of the Nordic Society for Medical Mycology. KEYNOTE SPEAKERS 4 One Health, but more than one strain: the case of Klebsiella Sylvain Brisse Sylvain Brisse is Research Director at Institut Pasteur and the Head of the research Unit Biodiversity and Epidemiology of Bacterial Pathogens. He is also the Director of two French National Reference Centers, in charge of the microbiological surveillance of diphtheria and whooping cough. He also acts as Director of the Biological Resource Center of Institut Pasteur. Previously he worked on Trypanosoma cruzi and Chagas disease in Bolivia, obtained his PhD in tropical parasitology and evolutionary genetics in Montpellier University, held a 5-year postdoctoral position in clinical microbiology in Utrecht, Netherlands, and headed a core facility for genotyping and genomic studies of microbial pathogens in Institut Pasteur. His research interests include the population biology and evolution of pathogenic microbial species, and their applications in epidemiological surveillance, diagnostics and public health. His main focus is on the multidrug resistant pathogen Klebsiella pneumoniae and on Bordetella pertussis and Corynebacterium diphtheriae. He also develops and maintains widely adopted strain nomenclatures that allow global and cross-sectorial tracking of bacterial sublineages. Ethics and OHEJP research: Supporting researchers when dealing with ethical issues François Hirsch Graduated in immunology and in Science & Medical Ethics. He spent 30 years at the French Inserm holding various positions, including Secretary General of the ethics committee and Deputy Director of the Health Technologies Institute. For three years, he was a national expert seconded to the European Commission, where he contributed to the organization of the ethics evaluation of research projects. He is currently a member of the Inserm Ethics Committee, Secretary General of one of the French registered IRBs and of the International Association for Responsible Research In Genome Editing (ARRIGE). He is an ethics evaluator for various EC agencies, a member of the European network of research ethics committees. For many years, he is involved in initiatives aiming at training experts from LMICs in ethics and biomedical research, and at establishing guidelines for the conduct of ethical research with vulnerable populations. Kate Millar Kate Millar is Professor of Applied Bioethics and Technology Assessment and Director of the Centre for Applied Bioethics, School of Biosciences and School of Veterinary Medicine and Science. Kate’s work focusses on animal, biotechnology and agri-food ethics, the development of ethical frameworks (e.g. the Ethical Matrix), publics / stakeholder engagement and biosciences research ethics training approaches. Kate has extensive international and UK research experience with current work funded by the Bill and Melinda Gates Foundation (BMGF), EC H2020, The Wellcome Trust, UK BBSRC and EPSRC, as well as charities such as the 3Rs organisation, FRAME. Kate is President of the European Society for Agricultural and Food Ethics (EurSafe). She is on the Editorial Board of Food Ethics (Springer). She serves on a number of UK and international ethics advisory committees and international research funding boards. She was recently appointed as a visiting academic at Centre of Bioethics in Southern and Eastern Africa-(CEBESA), College of Medicine, University of Malawi. What will cause the next pandemic? Mark Woolhouse Mark Woolhouse has been Professor of Infectious Disease Epidemiology at the University of Edinburgh since 1997. He studied biology at the Universities of Oxford and York and Queen’s in Canada, then held Research Fellowships at the University of Zimbabwe, Imperial College London and Oxford. His research interests concern the population dynamics of pathogens at the human-animal interface, especially those associated with antimicrobial resistance (AMR) and emerging infectious diseases. He regularly advises governments and national and international agencies. He was awarded an OBE in 2002 and is a Fellow of the Royal Society of Edinburgh, the Academy of Medical Sciences and the African Academy of Sciences. LIST OF ORAL PRESENTATIONS 5 No. Title AN OUTBREAK OF SARS-COV-2 IN MINK AND MINK FARMERS ASSOCIATED WITH COMMUNITY SPREAD,
Load more

Recommended publications
  • Isbn 978-625-409-353-1
    ISBN 978-625-409-353-1 INTERNATIONAL CONGRESS ON BIOLOGICAL AND HEALTH SCIENCES PROCEEDİNGS BOOK This work is subject to copyright and all rights reserved, whether the whole or part of the material is concerned. The right to publish this book belongs to International Congress on Biological and Health Sciences-2021. No part of this publication may be translated, reproduced, stored in a computerized system, or transmitted in any form or by any means, including, but not limited to electronic, mechanical, photocopying, recording without written permission from the publisher. This Proceedings Book has been published as an electronic publication (e-book). The publisher is not responsible for possible damages, which may be a result of content derived from this electronic publication All authors are responsible for the contents of their abstracts. https://www.biohealthcongress.com/ ([email protected]) Editor Ulaş ACARÖZ Published: 28/03/2021 ISBN: Editor's Note The first ‘International Congress on Biological and Health Sciences’ was organized online and free of charge. We are very happy and proud that various health science-related fields attended the congress. By this event, the distinguished and respected scientists came together to exchange ideas, develop and implement new researches and joint projects. There were 15 invited speakers from 10 different countries and also approximately 400 submissions were accepted from more than 20 countries. We would like to thank all participants and supporters. Hope to see you at our next congress.
    [Show full text]
  • Tese Carlos 2018
    UFRRJ PRÓ-REITORIA DE PESQUISA E PÓS-GRADUAÇÃO PROGRAMA DE PÓS-GRADUAÇÃO EM CIÊNCIA, TECNOLOGIA E INOVAÇÃO EM AGROPECUÁRIA TESE Estudo da Microbiota Bacteriana Endofítica de Cana-de-açúcar por Métodos Independentes de Cultivo: Diversidade, Perfil Taxonômico e Predição de Funções de Interesse Biotecnológico Carlos Magno dos Santos 2018 UNIVERSIDADE FEDERAL RURAL DO RIO DE JANEIRO PRÓ-REITORIA DE PESQUISA E PÓS-GRADUAÇÃO PROGRAMA DE PÓS-GRADUAÇÃO EM CIÊNCIA, TECNOLOGIA E INOVAÇÃO EM AGROPECUÁRIA ESTUDO DA MICROBIOTA BACTERIANA ENDOFÍTICA DE CANA- DE-AÇÚCAR POR MÉTODOS INDEPENDENTES DE CULTIVO: DIVERSIDADE, PERFIL TAXONÔMICO E PREDIÇÃO DE FUNÇÕES DE INTERESSE BIOTECNOLÓGICO CARLOS MAGNO DOS SANTOS Sob a Orientação do Pesquisador Stefan Schwab e Coorientação do Pesquisador José Ivo Baldani Tese submetida como requisito parcial para obtenção do grau de Doutor, no Programa de Pós- graduação em Ciência, Tecnologia e Inovação em Agropecuária, Área de Concentração em Agrobiologia Seropédica, RJ Fevereiro, 2018 Santos, Carlos Magno dos, 1990- S237e Estudo da microbiota bacteriana endofítica de cana de-açúcar por métodos independentes de cultivo: diversidade, perfil taxonômico e predição de funções de interesse biotecnológico / Carlos Magno dos Santos Santos. - 2018. 131 f.: il. Orientador: Stefan Schwab. Coorientador: José Ivo Baldani. Tese(Doutorado). -- Universidade Federal Rural do Rio de Janeiro, Ciência, Tecnologia e Inovação em Agropecuária, 2018. 1. Enriquecimento celular. 2. Independente de cultivo. 3. Líquido do apoplasto. 4. Colmo. 5. Sphingomonas. I. Schwab, Stefan, 1975-, orient. II. Baldani, José Ivo, 1953-, coorient. III Universidade Federal Rural do Rio de Janeiro. Ciência, Tecnologia e Inovação em Agropecuária. IV. Título. É permitida a cópia parcial ou total desta Tese, desde que citada a fonte.
    [Show full text]
  • Examining the Antimicrobial Activity of Cefepime-Taniborbactam
    Examining the antimicrobial activity of cefepime-taniborbactam (formerly cefepime/VNRX-5133) against Burkholderia species isolated from cystic fibrosis patients in the United States Elise T. Zeiser1, Scott A. Becka1, John J. LiPuma2, David A. Six 3, Greg Moeck 3, and Krisztina M. Papp-Wallace1,4 1Veterans Affairs Northeast Ohio Healthcare System, Cleveland, OH; 2University of Michigan, Ann Arbor, MI; 3Venatorx 4 Pharmaceuticals, Inc., Malvern, PA; and Case Western Reserve University, Cleveland, OH Correspondence to: [email protected] Abstract Results Background: Burkholderia cepacia complex (Bcc), a group of >20 related species, and B. gladioli are 60 opportunistic human pathogens that cause chronic infections in people with cystic fibrosis (CF) or cefepime compromised immune systems. Ceftazidime and trimethoprim-sulfamethoxazole are first-line agents used to treat infections due to Burkholderia spp. However, these species have developed resistance to cefepime-taniborbactam many antibiotics, including first-line therapies. β-lactam resistance in Burkholderia species is largely 40 mediated by PenA-like chromosomal class A β-lactamases. A novel investigational β-lactam/β-lactamase inhibitor combination, cefepime-taniborbactam (formerly cefepime/VNRX-5133) demonstrates potent antimicrobial activity against gram-negative bacteria producing class A, B, C, and D β-lactamases. The activity of cefepime-taniborbactam was investigated against Bcc and B. gladioli; moreover, the biochemical activity of taniborbactam against the PenA1 carbapenemase was evaluated. 20 Methods: CLSI-based agar dilution antimicrobial susceptibility testing using cefepime and cefepime combined with taniborbactam at 4 mg/L was conducted against a curated panel of 150 Burkholderia species obtained from the Burkholderia cepacia Research Laboratory and Repository. Isolates were Number isolates of recovered from respiratory specimens from 150 different individuals with CF receiving care in 68 cities 0 throughout 36 states within the United States.
    [Show full text]
  • Yersinia Enterocolitica
    TECHNISCHE UNIVERSITÄT MÜNCHEN Lehrstuhl für Mikrobielle Ökologie Regulation und Freisetzung des insektiziden Komplexes in Yersinia enterocolitica Mandy Starke Vollständiger Abdruck der von der Fakultät Wissenschaftszentrum Weihenstephan für Ernährung, Landnutzung und Umwelt der Technischen Universität München zur Erlangung des akademischen Grades eines Doktors der Naturwissenschaften genehmigten Dissertation. Vorsitzender: Univ.- Prof. Dr. W. Liebl Prüfer der Dissertation: 1. apl. Prof. Dr. T. Fuchs 2. Univ.-Prof. Dr. M. Hofrichter (nur schriftliche Beurteilung) Technische Universität Dresden Univ.-Prof. Dr. S. Scherer (nur mündliche Prüfung) 3. Univ.-Prof. Dr. J. Heesemann (i.R.) Ludwigs-Maximilians-Universität München Die Dissertation wurde am 10.11.2014 bei der Technischen Universität München eingereicht und durch die Fakultät Wissenschaftszentrum Weihenstephan für Ernährung, Landnutzung und Umwelt am 17.03.2015 angenommen. “Alles Wissen und alle Vermehrung unseres Wissens endet nicht mit einem Schlusspunkt, sondern mit einem Fragezeichen.“ -Hermann Hesse- Inhaltsverzeichnis I Inhaltsverzeichnis ABBILDUNGSVERZEICHNIS ........................................................................................................... V TABELLENVERZEICHNIS .............................................................................................................. VII ABKÜRZUNGSVERZEICHNIS ..................................................................................................... VIII ZUSAMMENFASSUNG ...................................................................................................................
    [Show full text]
  • Table S4. Phylogenetic Distribution of Bacterial and Archaea Genomes in Groups A, B, C, D, and X
    Table S4. Phylogenetic distribution of bacterial and archaea genomes in groups A, B, C, D, and X. Group A a: Total number of genomes in the taxon b: Number of group A genomes in the taxon c: Percentage of group A genomes in the taxon a b c cellular organisms 5007 2974 59.4 |__ Bacteria 4769 2935 61.5 | |__ Proteobacteria 1854 1570 84.7 | | |__ Gammaproteobacteria 711 631 88.7 | | | |__ Enterobacterales 112 97 86.6 | | | | |__ Enterobacteriaceae 41 32 78.0 | | | | | |__ unclassified Enterobacteriaceae 13 7 53.8 | | | | |__ Erwiniaceae 30 28 93.3 | | | | | |__ Erwinia 10 10 100.0 | | | | | |__ Buchnera 8 8 100.0 | | | | | | |__ Buchnera aphidicola 8 8 100.0 | | | | | |__ Pantoea 8 8 100.0 | | | | |__ Yersiniaceae 14 14 100.0 | | | | | |__ Serratia 8 8 100.0 | | | | |__ Morganellaceae 13 10 76.9 | | | | |__ Pectobacteriaceae 8 8 100.0 | | | |__ Alteromonadales 94 94 100.0 | | | | |__ Alteromonadaceae 34 34 100.0 | | | | | |__ Marinobacter 12 12 100.0 | | | | |__ Shewanellaceae 17 17 100.0 | | | | | |__ Shewanella 17 17 100.0 | | | | |__ Pseudoalteromonadaceae 16 16 100.0 | | | | | |__ Pseudoalteromonas 15 15 100.0 | | | | |__ Idiomarinaceae 9 9 100.0 | | | | | |__ Idiomarina 9 9 100.0 | | | | |__ Colwelliaceae 6 6 100.0 | | | |__ Pseudomonadales 81 81 100.0 | | | | |__ Moraxellaceae 41 41 100.0 | | | | | |__ Acinetobacter 25 25 100.0 | | | | | |__ Psychrobacter 8 8 100.0 | | | | | |__ Moraxella 6 6 100.0 | | | | |__ Pseudomonadaceae 40 40 100.0 | | | | | |__ Pseudomonas 38 38 100.0 | | | |__ Oceanospirillales 73 72 98.6 | | | | |__ Oceanospirillaceae
    [Show full text]
  • Extensive Microbial Diversity Within the Chicken Gut Microbiome Revealed by Metagenomics and Culture
    Extensive microbial diversity within the chicken gut microbiome revealed by metagenomics and culture Rachel Gilroy1, Anuradha Ravi1, Maria Getino2, Isabella Pursley2, Daniel L. Horton2, Nabil-Fareed Alikhan1, Dave Baker1, Karim Gharbi3, Neil Hall3,4, Mick Watson5, Evelien M. Adriaenssens1, Ebenezer Foster-Nyarko1, Sheikh Jarju6, Arss Secka7, Martin Antonio6, Aharon Oren8, Roy R. Chaudhuri9, Roberto La Ragione2, Falk Hildebrand1,3 and Mark J. Pallen1,2,4 1 Quadram Institute Bioscience, Norwich, UK 2 School of Veterinary Medicine, University of Surrey, Guildford, UK 3 Earlham Institute, Norwich Research Park, Norwich, UK 4 University of East Anglia, Norwich, UK 5 Roslin Institute, University of Edinburgh, Edinburgh, UK 6 Medical Research Council Unit The Gambia at the London School of Hygiene and Tropical Medicine, Atlantic Boulevard, Banjul, The Gambia 7 West Africa Livestock Innovation Centre, Banjul, The Gambia 8 Department of Plant and Environmental Sciences, The Alexander Silberman Institute of Life Sciences, Edmond J. Safra Campus, Hebrew University of Jerusalem, Jerusalem, Israel 9 Department of Molecular Biology and Biotechnology, University of Sheffield, Sheffield, UK ABSTRACT Background: The chicken is the most abundant food animal in the world. However, despite its importance, the chicken gut microbiome remains largely undefined. Here, we exploit culture-independent and culture-dependent approaches to reveal extensive taxonomic diversity within this complex microbial community. Results: We performed metagenomic sequencing of fifty chicken faecal samples from Submitted 4 December 2020 two breeds and analysed these, alongside all (n = 582) relevant publicly available Accepted 22 January 2021 chicken metagenomes, to cluster over 20 million non-redundant genes and to Published 6 April 2021 construct over 5,500 metagenome-assembled bacterial genomes.
    [Show full text]
  • 1985517720.Pdf
    JOURNAL OF BACTERIOLOGY, Jan. 2009, p. 347–354 Vol. 191, No. 1 0021-9193/09/$08.00ϩ0 doi:10.1128/JB.01238-08 Copyright © 2009, American Society for Microbiology. All Rights Reserved. Complete Genome Sequence and Comparative Genome Analysis of Enteropathogenic Escherichia coli O127:H6 Strain E2348/69ᰔ† Atsushi Iguchi,1 Nicholas R. Thomson,2 Yoshitoshi Ogura,1,3 David Saunders,2 Tadasuke Ooka,3 Ian R. Henderson,4 David Harris,2 M. Asadulghani,1 Ken Kurokawa,5 Paul Dean,6 Brendan Kenny,6 Michael A. Quail,2 Scott Thurston,2 Gordon Dougan,2 Tetsuya Hayashi,1,3 Julian Parkhill,2 and Gad Frankel7* Division of Bioenvironmental Science, Frontier Science Research Center,1 and Division of Microbiology, Department of Infectious Diseases, Faculty of Medicine,3 University of Miyazaki, Miyazaki, Japan; Pathogen Genomics, The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, United Kingdom2; School of Immunity and Infection, University of Downloaded from Birmingham, Birmingham, United Kingdom4; Department of Biological Information, School and Graduate School of Bioscience and Biotechnology, Tokyo Institute of Technology, Kanagawa, Japan5; Institute of Cell and Molecular Biosciences, University of Newcastle, Newcastle upon Tyne, United Kingdom6; and Centre for Molecular Microbiology and Infection, Division of Cell and Molecular Biology, Imperial College London, London, United Kingdom7 Received 5 September 2008/Accepted 15 October 2008 Enteropathogenic Escherichia coli (EPEC) was the first pathovar of E. coli to be implicated in human disease; however, no EPEC strain has been fully sequenced until now. Strain E2348/69 (serotype O127:H6 belonging to E. http://jb.asm.org/ coli phylogroup B2) has been used worldwide as a prototype strain to study EPEC biology, genetics, and virulence.
    [Show full text]
  • Aliarcobacter Butzleri from Water Poultry: Insights Into Antimicrobial Resistance, Virulence and Heavy Metal Resistance
    G C A T T A C G G C A T genes Article Aliarcobacter butzleri from Water Poultry: Insights into Antimicrobial Resistance, Virulence and Heavy Metal Resistance Eva Müller, Mostafa Y. Abdel-Glil * , Helmut Hotzel, Ingrid Hänel and Herbert Tomaso Institute of Bacterial Infections and Zoonoses (IBIZ), Friedrich-Loeffler-Institut, Federal Research Institute for Animal Health, 07743 Jena, Germany; Eva.Mueller@fli.de (E.M.); Helmut.Hotzel@fli.de (H.H.); [email protected] (I.H.); Herbert.Tomaso@fli.de (H.T.) * Correspondence: Mostafa.AbdelGlil@fli.de Received: 28 July 2020; Accepted: 16 September 2020; Published: 21 September 2020 Abstract: Aliarcobacter butzleri is the most prevalent Aliarcobacter species and has been isolated from a wide variety of sources. This species is an emerging foodborne and zoonotic pathogen because the bacteria can be transmitted by contaminated food or water and can cause acute enteritis in humans. Currently, there is no database to identify antimicrobial/heavy metal resistance and virulence-associated genes specific for A. butzleri. The aim of this study was to investigate the antimicrobial susceptibility and resistance profile of two A. butzleri isolates from Muscovy ducks (Cairina moschata) reared on a water poultry farm in Thuringia, Germany, and to create a database to fill this capability gap. The taxonomic classification revealed that the isolates belong to the Aliarcobacter gen. nov. as A. butzleri comb. nov. The antibiotic susceptibility was determined using the gradient strip method. While one of the isolates was resistant to five antibiotics, the other isolate was resistant to only two antibiotics. The presence of antimicrobial/heavy metal resistance genes and virulence determinants was determined using two custom-made databases.
    [Show full text]
  • Quadram Institute Newsletter
    Autumn 2019 Welcome to the newsle�er of the Quadram Ins�tute. This issue highlights recent research breakthroughs at the We con�nue to build our team and are pleased to welcome Quadram Ins�tute (QI) that could have posi�ve impacts on Professor Cynthia Whitchurch to the QI. Cynthia is se�ng public health. Working with clinicians our researchers have up a research group inves�ga�ng bacterial lifestyles, and shown how the latest sequencing technologies can aid in how these make them more infec�ous or resistant to diagnos�cs and surveillance. Coupling these techniques an�microbials. Cynthia joins us from the ithree ins�tute at with ‘Big Data’ analy�cal approaches will be vital to the University of Technology Sydney. Her research led to addressing 21st century popula�on health challenges, and the discovery that extracellular DNA is required for biofilm the QI aims to be a leader in this area. development. Big Data in the NHS was the topic of a roundtable We con�nue to welcome visitors to our new building to discussion I a�ended with Patricia Hart at the policy share our vision to understand how food and microbes development think tank Reform. This roundtable was interact to promote health and prevent disease. In June, we sponsored by QI and explored how universi�es and industry had the honour of hos�ng His Excellency Simon Smits, can work with government to realise poten�al applica�ons Ambassador of the Netherlands to the UK. The Ambassador of Big Data. The event was chaired by Baroness Blackwood, visited the Norwich Research Park as part of an Parliamentary Under-Secretary of State, Department of interna�onal trade delega�on to East Anglia to learn about Health and Social Care (DHSC) and included senior the region’s world-leading life sciences research and trade policy-makers, public service prac��oners, academics and opportuni�es.
    [Show full text]
  • Curriculum Vitae Professor Mark John Pallen
    Curriculum Vitae Professor Mark John Pallen MA (Hons) Cantab, MBBS, MD, PhD January 2014 Mark Pallen — Curriculum vitae Personal Details Name Mark John Pallen Date of Birth 6 July 1960 Nationality British Address 17 Lodge Drive, Malvern Worcestershire, WR14 4LS E-mail address [email protected] Telephone 01684 567710 (home); 07824 086946 (mobile) Web Page: http://tinyurl.com/ncul2p3 Twitter: http://twitter.com/mjpallen YouTube Channel: http://www.youtube.com/user/pallenm/ Education and Qualifications PhD 1998 Imperial College, London An investigation into the links between stationary phase and virulence in Salmonella enterica enterica serovar Typhimurium MD 1993 St Bartholomew's Hospital Medical College Detection and characterisation of diphtheria toxin genes and insertion sequences MRCPath by examination in Medical Microbiology 1991 (upgraded to FRCPath 2005) MB BS 1981-84 London Hospital Medical College Undergraduate Prizes: LEPRA National Essay Prize, 1982 Turnbull Prize in Pathology, 1983, 1984 Sutton Prize in Pathology, 1983 BA (Hons) in Medical Sciences 1978-81 University of Cambridge Fitzwilliam College (Lower Second, converted to MA, 1985) Page 1 Mark Pallen — Curriculum vitae Employment Professor of Microbial Genomics Head of Division of Microbiology and Infection Apr 2013-now Warwick Medical School, University of Warwick Professor of Microbial Genomics 2001-2013 University of Birmingham Professor and Head of Department 1999-2001 Department of Microbiology and Immunobiology Queen’s University, Belfast Senior Lecturer (Honorary Consultant) 1992–99 Department of Medical Microbiology St Bartholomew's and the Royal London School of Medicine and Dentistry (Queen Mary Westfield College) Visiting Research Fellow 1994–97 Department of Biochemistry Imperial College of Science, Technology and Medicine (on a Wellcome Trust Research Leave Fellowship, working at Imperial, while still employed by Barts) Lecturer (Hon.
    [Show full text]
  • Epidemiology and Comparative Analysis of Yersinia in Ireland Author(S) Ringwood, Tamara Publication Date 2013 Original Citation Ringwood, T
    UCC Library and UCC researchers have made this item openly available. Please let us know how this has helped you. Thanks! Title Epidemiology and comparative analysis of Yersinia in Ireland Author(s) Ringwood, Tamara Publication date 2013 Original citation Ringwood, T. 2013. Epidemiology and comparative analysis of Yersinia in Ireland. PhD Thesis, University College Cork. Type of publication Doctoral thesis Rights © 2013, Tamara Ringwood http://creativecommons.org/licenses/by-nc-nd/3.0/ Item downloaded http://hdl.handle.net/10468/1294 from Downloaded on 2021-10-07T12:07:10Z Epidemiology and Comparative Analysis of Yersinia in Ireland by Tamara Ringwood A thesis presented for the Degree of Doctor of Philosophy National University of Ireland, Cork University College Cork Coláiste na hOllscoile Corcaigh Department of Microbiology Head of Department: Prof. Gerald F. Fitzgerald Supervisor: Prof. Michael B. Prentice April 2013 Contents List of Tables .............................................................................................................................................. iv List of figures ............................................................................................................................................. vi Declaration ............................................................................................................................................... viii Acknowledgements ................................................................................................................................
    [Show full text]
  • Clinical Isolates of Yersinia Enterocolitica in Finland 117 2013 117
    Leila M. Sihvonen Leila Leila M. Sihvonen Clinical isolates of Yersinia enterocolitica in Finland Leila M. Sihvonen Identification and Epidemiology Clinical isolates of Yersinia enterocolitica in Finland Identification and Epidemiology Clinical isolates of Clinical isolates Yersinia enterocolitica is a foodborne bacterium that causes gastroenteritis and post-infectious complications, such as reactive arthritis, in humans. Y. enterocolitica species is divided into six biotypes, which differ in their ability to cause illness. The Y. enterocolitica incidence in Finland has been among the highest in the EU, but there has been little information on the occurrence of different Y. enterocolitica biotypes. enterocolitica Yersinia In this thesis Y. enterocolitica strains isolated from Finnish patients were characterised and the symptoms and sources of infections were analysed RESEARCH RESEARCH in a case-control study. The majority of clinical isolates of Y. enterocolitica were found to belong to biotype 1A, the status of which as a true pathogen is controversial. Furthermore, the study investigated the microbiological identification and molecular typing methods for Y. enterocolitica. The MLVA method was found to be appropriate for investigating foodborne outbreaks. in Finland This study adds to the understanding of epidemiology of Y. enterocolitica in Finland and emphasises the importance of correct identification of Yersinia strains in order to evaluate the clinical importance of the microbiological findings. National Institute for Health and Welfare P.O. Box 30 (Mannerheimintie 166) FI-00271 Helsinki, Finland 117 Telephone: 358 29 524 6000 117 117 2013 ISBN 978-952-302-064-1 www.thl.fi RESEARCH NRO 117 2014 Leila M. Sihvonen Clinical isolates of Yersinia enterocolitica in Finland Identification and Epidemiology ACADEMIC DISSERTATION To be presented with the permission of the Faculty of Agriculture and Forestry, University of Helsinki, for public examination in Auditorium 1041, Biocenter 2, Viikinkaari 5, on 17.01.2014, at 12 noon.
    [Show full text]